The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials. Read more about The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials.
Cervical cancer screening in women over 65. CON: Reasons for uncertainty. Read more about Cervical cancer screening in women over 65. CON: Reasons for uncertainty.
Summary of the 2016 American Association for Cancer Research (AACR) Annual Meeting. Read more about Summary of the 2016 American Association for Cancer Research (AACR) Annual Meeting.
A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results. Read more about A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results.
Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery. Read more about Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery.
Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients. Read more about Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Read more about No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N. Read more about Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N.
Post-operative enteral immunonutrition for gynecologic oncology patients undergoing laparotomy decreases wound complications. Read more about Post-operative enteral immunonutrition for gynecologic oncology patients undergoing laparotomy decreases wound complications.
